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Background: Few studies have systematically examined whether knowledge translation (KT) strategies can be
successfully implemented within the long-term care (LTC) setting. In this study, we examined the effectiveness of a
multifaceted, interdisciplinary KT intervention for improving the prescribing of vitamin D, calcium and osteoporosis
medications over 12-months.
Methods: We conducted a pilot, cluster randomized controlled trial in 40 LTC homes (21 control; 19 intervention)
in Ontario, Canada. LTC homes were eligible if they had more than one prescribing physician and received services
from a large pharmacy provider. Participants were interdisciplinary care teams (physicians, nurses, consultant
pharmacists, and other staff) who met quarterly. Intervention homes participated in three educational meetings
over 12 months, including a standardized presentation led by expert opinion leaders, action planning for quality
improvement, and audit and feedback review. Control homes did not receive any additional intervention. Resident-
level prescribing and clinical outcomes were collected from the pharmacy database; data collectors and analysts
were blinded. In addition to feasibility measures, study outcomes were the proportion of residents taking vitamin D
(≥800 IU/daily; primary), calcium ≥500 mg/day and osteoporosis medications (high-risk residents) over 12 months.
Data were analyzed using the generalized estimating equations technique accounting for clustering within the LTC
homes.
Results: At baseline, 5,478 residents, mean age 84.4 (standard deviation (SD) 10.9), 71% female, resided in 40 LTC
homes, mean size = 137 beds (SD 76.7). In the intention-to-treat analysis (21 control; 19 intervention clusters), the
intervention resulted in a significantly greater increase in prescribing from baseline to 12 months between intervention
versus control arms for vitamin D (odds ratio (OR) 1.82, 95% confidence interval (CI): 1.12, 2.96) and calcium (OR 1.33,
95% CI: 1.01, 1.74), but not for osteoporosis medications (OR 1.17, 95% CI: 0.91, 1.51). In secondary analyses, excluding
seven nonparticipating intervention homes, ORs were 3.06 (95% CI: 2.18, 4.29), 1.57 (95% CI: 1.12, 2.21), 1.20 (95% CI:
0.90, 1.60) for vitamin D, calcium and osteoporosis medications, respectively.
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Conclusions: Our KT intervention significantly improved the prescribing of vitamin D and calcium and is a model that
could potentially be applied to other areas requiring quality improvement.
Trial Registration: ClinicalTrials.gov: NCT01398527. Registered: 19 July 2011.
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Effective knowledge translation (KT) interventions are
essential to encourage the uptake of evidence-based
practices. Ideally, the selection of interventions is guided
by evidence of effectiveness and efficiency [1]; however,
good evidence is not always available or may not be
generalizable from one setting to another. Compared
with community or acute care settings, there has been
little KT enquiry in long-term care (LTC) homes [2].
LTC homes provide 24-hour nursing care and supervi-
sion to residents who often have multiple comorbidities,
polypharmacy, and shortened life expectancies. Physi-
cians are often located offsite and engage in collaborative
decision making with the care team [3]. Given these
characteristics, KT strategies need to be targeted at the
interdisciplinary team and be tailored to this unique prac-
tice environment [4]. Furthermore, rigorous evaluation is
required to ascertain whether KT strategies proven to be
effective in other care settings are also effective in LTC.
The Vitamin D and Osteoporosis Study (ViDOS) was
a pilot, cluster randomized controlled trial that exam-
ined both feasibility and prescribing changes as primary
outcomes. Pilot trials are designed to assess a number of
feasibility objectives prior to conducting a larger trial [5].
Particularly in situations where there is little previous
data to inform the process, pilot trials are considered es-
sential prerequisites that will enhance success of a future,
wide-scale trial (ibid). Given the considerable resources
required to implement such a trial, in addition to examin-
ing feasibility outcomes, we appropriately powered the
study to assess the statistical significance of our primary
prescribing outcome.
The knowledge being translated in the ViDOS inter-
vention was evidence-based osteoporosis and fracture
prevention strategies, particularly wide-scale, appropriate
vitamin D prescribing. An estimated 60 to 80% of LTC
residents have osteoporosis [6], and in Canada, it is
estimated that the fracture rate for LTC residents is ap-
proximately 2 to 4 times that of similarly aged community-
dwelling residents [7]. Meta-analyses demonstrate that
vitamin D reduces falls [8], and calcium and vitamin D re-
duce fractures in LTC residents [9]. Despite strong evi-
dence and acceptance by physicians [10], these strategies
are under-utilized in LTC [11,12]. Barriers to implementing
appropriate fracture prevention include knowledge gaps
[13,14], lack of access to bone densitometry, difficulty inapplying risk assessment tools within LTC [14], and a lack
of organizational processes and policies that support bone
health [15]. Our overall aim was to examine a knowledge
translation model for delivering evidence-based practices
within LTC homes that utilized a standard method of de-
livery and also addressed the unique learning needs of each
home. Targeting interdisciplinary care teams (including
medicine, nursing, rehabilitation, and nutrition), our multi-
faceted model utilized common professional interventions
(for example, educational meetings, audit and feedback)
and included elements of quality improvement. Reflecting
the critical need to target whole system change when
implementing evidence into practice [16], particularly in
LTC [17], our intervention emphasized home-level process
and policy changes.
The focus of the current article is on prescribing
changes; feasibility and fidelity results of the ViDOS trial
are published elsewhere [18]. Our primary prescribing
objective was to determine if the intervention increased
the proportion of all residents prescribed vitamin D
≥800 IU over 12 months. Secondary objectives were to
examine the influence of the intervention on 1) calcium
prescribing and 2) osteoporosis medication prescribing
for high-risk residents.Methods
Trial design and setting
The protocol for this trial (NCT01398527) has been
published [19]. The Vitamin D and Osteoporosis Study
(ViDOS) was a pilot, cluster randomized control trial
(RCT) conducted in 40 LTC homes across the province
of Ontario, Canada. In Ontario, there are approximately
630 licensed LTC homes that provide residents with
onsite nursing care, 24-hour supervision, or personal
support [20].
The trial had two arms: 19 LTC homes were assigned to
the intervention group and 21 LTC homes were assigned
to a control group (Figure 1). Cluster randomization was
chosen due to the natural care clusters (the same profes-
sionals caring for residents) in LTC homes. In addition,
we wished to minimize the potential for contamination
between trial arms given that professionals in the same
home may alter their practice for all residents. Further-
more, the ViDOS intervention targeted both individual
prescribing physicians and home-level changes.
Figure 1 Flow-chart of randomization, allocation, follow-up and analysis.
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geriatric medicine and clinical trials met twice to review
trial processes. Informed consent was obtained from a
representative at each LTC home and from individual
professionals. The study was approved by the McMaster
University/Hamilton Health Sciences Research Ethics
Board (Reference #:09–215).
Recruitment of clusters
Our sampling frame was LTC homes who received
medication and consulting services from Medical Phar-
macies Group Limited, a large provider delivering ser-
vices to approximately one-third of Ontario LTC homes.
Homes were eligible if they had more than one prescrib-
ing physician and received services from Medical Phar-
macies. There were no resident-level exclusion criteria.
Our recruitment strategy included homes located in
communities of all sizes and geographical regions across
Ontario. Recruitment began in 2009 and was ongoing
until the target sample size was reached. The final home
completed the intervention in 2012.
Participants
The target audience within each LTC home was the core
group of interdisciplinary care leaders (that is, theprofessional advisory committee). Depending on the size
of the LTC home, this group included the medical dir-
ector, director/assistant director of care, administrator,
consultant pharmacist, food services director, other pre-
scribing physicians, nurse practitioners, registered nurses,
dieticians, and physiotherapists. Participation in the
ViDOS intervention sessions is fully described elsewhere
[18].
Randomization and blinding
LTC homes were allocated to control or intervention
arms (1:1 allocation ratio) using stratified, block
randomization. Stratified allocation was based on home
size (<250 versus ≥250 beds) and profit/nonprofit status.
An offsite investigator assigned homes to treatment
groups based on a computer-generated allocation se-
quence. The database manager and analysts were
blinded to allocation status; LTC homes, experts, and co-
ordinators were not blinded.
Intervention
The design and implementation of our 12-month, multifa-
ceted intervention (Figure 2) was founded on the Canadian
Institutes of Health Research Knowledge-to-Action cycle
[21], described in the study protocol [19].
Figure 2 ViDOS multifaceted intervention.
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Informal “champions” (typically Directors of Care)
worked with the research team to book educational
meetings and encourage participation. Educational meet-
ings had a combination of didactic presentation and
interactive activities. Three, small-group, educational
meetings, were held at each intervention home during
approximately months 1, 6 and 12. Meetings were one-
hour in length, typically had 5 to 10 participants, and
were facilitated by one of six expert opinion leadersa
[22], who were specialist physicians with expertise in
osteoporosis or geriatrics. Experts engaged with study
participants either in-person (meeting one only) or re-
motely; the study coordinator was on-site at the first two
meetings to distribute/collect study materials and to fa-
cilitate the process (for example, connecting with the ex-
pert if remotely conducted). At each meeting, the expert
delivered a standardized presentation reviewing best
practices for osteoporosis management and fracture pre-
vention (including case studies) with an emphasis on the
importance of vitamin D for preventing falls and frac-
tures. A question and answer session followed the
presentation.
Action planning for quality improvement
After the presentation, interdisciplinary teams engaged
in action planning based on the “plan-do-study-act”
cycle [19,23]. Interdisciplinary care teams brainstormed re-
garding barriers and facilitators to implementing evidence-
based strategies, particularly changes that could be made at
an organizational level. An action plan worksheet was
completed/updated at each educational meeting, which
outlined specific tasks and steps for implementing process/
policy changes. Ideas generated by teams were shared
among LTC homes.
Audit and feedback reports
During the session, experts reviewed home-level audit
and feedback reports with the interdisciplinary team. Re-
ports included 1) vitamin D, calcium, and osteoporosis
medication prescribing (based on previous month),which was benchmarked against other study homes; and
2) a summary of the falls and fractures occurring in the
home in the previous 3 months. Confidential audit and
feedback reports were also provided to each physician,
containing a prescribing summary for their roster of
patients.
Educational materials
Educational materials distributed included Ontario Osteo-
porosis Strategy [24] fracture prevention toolkits (ibid),
process checklists, and paper-based treatment alerts to as-
sist consultant pharmacists with flagging high-risk individ-
uals [19].
Changes to intervention
The expert attended the initial educational meeting in-
person at the first seven homes; it was not feasible to
continue with this format, and the remainders were con-
ducted remotely. We planned to use webinar technology
to conduct the educational meetings; however, many
homes did not have an accessible internet connection,
and experts facilitated meetings via teleconference
instead.
Control arm
Control homes received no intervention except fracture
prevention toolkits provided to all LTC homes in the prov-
ince by the Ontario Osteoporosis Strategy [24]; Osteopor-
osis Long-term care [www.osteoporosislongtermcare.ca].
Outcomes
Resident-level, de-identified prescribing/clinical data
were obtained from the Medical Pharmacies central
database. Data captured were point prevalence estimates;
that is, medication/supplementation orders for all resi-
dents residing in the home on the day of the data down-
load. Data were downloaded separately for each LTC
home at approximately baseline, 6 and 12 months, just
prior to the scheduled ViDOS educational sessionb. To
ensure that the timing of data downloads was balanced
between study arms throughout the study, data
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matched with an intervention home (the nearest one in
the randomization sequence).
The primary outcome was the change in the propor-
tion of all residents prescribed vitamin D ≥800 IU/day
(including vitamin D2 or D3) over 12 months. Secondary
prescribing outcomes were the change in 1) the propor-
tion of all residents prescribed calcium ≥500 mg/day and
2) high-risk residents prescribed an osteoporosis medica-
tion (oral bisphosphonate, zoledronic acid, denosumab,
or teriparatide). Algorithms to calculate supplement dos-
age included all daily/weekly/monthly preparations and
medications and vitamin/mineral supplements that con-
tain vitamin D and calcium. High-risk residents were
those with a documented hip fracture, vertebral fracture,
or osteoporosis diagnosis on the electronic Medication
Administration Record (eMAR). The eMAR captured
any medication indications or diagnoses that were
present at admission, and further updates may have oc-
curred when diagnoses were included on physician or-
ders or quarterly medication reviews.
Falls and fractures
The study was not powered to make comparisons be-
tween study arms regarding incident falls and fractures.
These data were collected to inform the feasibility of
data collection for future trials in this setting. Falls and
fracture data were collected for 3 months, in three non-
consecutive periods, coinciding with the educational
meetings for the intervention homes. Home-specific
feedback on the number of falls and fractures occurring
was included in the audit and feedback reports (inter-
vention homes only). Researchers provided the homes
with a standardized data collection sheet and homes
completed the information using various sources includ-
ing electronic/paper-based charts, internal monitoring
systems, Resident Assessment Instrument - Minimum
Data Set 2.0 (RAI-MDS 2.0), and critical incident
reports.
Sample size calculation
Given effect sizes observed in other KT interventions
(for example, mixed interactive and didactic educational
meetings [25]), we were interested in detecting a 15%
difference in prescribing of vitamin D ≥800 IU/daily be-
tween the groups (anticipating a 20% increase in the
intervention group, and a 5% increase in the control
group due to ongoing provincial initiatives [24]). Based
on prior work, we anticipated an average of 120 resi-
dents per LTC home and a baseline vitamin D (≥800 IU/
day) prescribing rate of 30% [11]. Assuming an intraclus-
ter correlation of 0.10 and a Type I error of 5%, we de-
termined that a sample size of 18 LTC homes (n = 2,160
residents) per arm was required to achieve 82% power.Factoring in a 10% dropout rate, the recruitment target
was 40 LTC homes.
Statistical analysis
Differences in baseline characteristics between arms
were examined using the chi-square procedure and inde-
pendent samples T-test. Our primary analysis was
intention-to-treat (ITT). To account for clustering
within a LTC home, we analyzed resident-level data
using the generalized estimating equations (GEE) tech-
nique, assuming an exchangeable correlation structure
which specifies that all observations within the same
cluster are equally correlated [26]. We examined the ef-
fect of the intervention on the change from baseline to
12 months in the proportion of residents prescribed vita-
min D ≥800 IU/day and calcium ≥500 mg/day (that is,
treatment group-by-time interaction). The same method
was used to examine osteoporosis medication prescrib-
ing, including only high-risk residents. Odds ratios
(ORs), corresponding 95% confidence intervals (CIs) are
reported.
Sensitivity analyses
The above analyses were also conducted in the per
protocol cohort, which excluded non-active intervention
homes. We also examined the effect of adjusting GEE
models for age, sex, and high-risk status.
Cluster-level analyses
For each outcome, we calculated the absolute prescrib-
ing change in each LTC home from baseline to 12-
months. We report mean home-level prescribing
changes within treatment arms and calculated the differ-
ence between arms, with 95% CIs adjusted for clustering
using the method described by Donner and Klar [27].
All statistical analyses were performed using the SAS/
STAT 9.2 software package (SAS Institute Inc., Cary,
NC, USA) and SPSS v20. The criterion for statistical sig-
nificance was set at ɑ = 0.05.
Results
The CONSORT flow diagram is displayed in Figure 1.
The baseline cohort consisted of 5,478 residents residing
in 40 LTC homes (19 intervention, 21 control). In total,
12 of the 19 intervention homes actively participated in
the intervention. Of the seven nonactive intervention
homes, six withdrew participation before beginning the
study and one withdrew after the first educational meet-
ing. The primary reasons for not participating were lo-
gistical or scheduling difficulties [18].
Facility characteristics
The majority of LTC homes in the study were for-profit
and affiliated with a multifacility chain (Table 1). The
Table 1 Baseline characteristics of intervention and
control long-term care homes
Characteristic Control Intervention
(n = 21) (n = 19)
Facility size (number of beds)
mean (SD), min, max
157 (80.2), 49, 375 115 (68.0), 43, 294
Number of prescribing physicians
mean (SD), min, max
4.3 (2.7), 2, 13 4.5 (2.7), 1, 10
Percent (n) of LTC homes located
in communities of various
population sizes
Small (<30,000) 33 (7) 47 (9)
Medium (30,000 - 100,000) 10 (2) 11 (2)
Large (100,000-1,000,000) 38 (8) 26 (5)
Metropolitan (>1,000,000) 19 (4) 16 (3)
For-profit, % 81 95
Chain affiliation, % 76 84
SD, standard deviation; min, minimum value; max, maximum value.
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ard deviation (SD) 80.2) versus intervention homes (115
beds, SD 67.9); however, both study arms had a similar
proportion of small (<100 beds) and large (>250 beds)
homes.
Resident characteristics
Residents in both arms were similar in baseline demo-
graphic characteristics. In the control arm, there was a
higher prevalence of hip fractures; osteoporosis diagno-
ses; and baseline use of vitamin D ≥800 IU/day, calcium
≥500 mg/day, and osteoporosis medications (Table 2).
Due to the correlated nature of clustered data and typic-
ally smaller number of units being randomized, achiev-
ing balance in baseline characteristics is less likely in
cluster trials compared with individual RCT’s [28].Table 2 Baseline characteristics of residents in intervention a
Characteristic Contr
n = 3
Age, mean (SD) 84.6 (
Female, % (n) 71.1 (
Number of medications, mean (SD) 9.2 (4
Vitamin D (≥800 IU/day), % (n) 41.8 (
Calcium (≥500 mg/day), % (n) 34.8 (
Osteoporosis medication, % (n) 22.7 (
High-risk residents,* % (n) 34.8 (
Hip fracture (prevalent), % (n) 7.0 (2
Vertebral fracture (prevalent), % (n) 1.4 (4
Osteoporosis diagnosis, % (n) 31.3 (
High-risk, % (n)* 36.0 (
SD, standard deviation; *Hip fracture, spine fracture, or osteoporosis diagnosis.Prescribing changes
The median lengths of follow-up between baseline and
final data download for all intervention, active interven-
tion, and control homes, respectively, were 12.4 (min
7.4, max 15.0)c, 12.2 (min 11.4, max 15.0), and 12.1 (min
10.5, max 13.4) months.
The main findings are presented in Table 3. In the
ITT cohort, GEE analyses indicated there was signifi-
cantly greater prescribing change from baseline to 12
months in the intervention versus control groups for
both vitamin D and calcium, with ORs 1.82 (95% CI:
1.12, 2.96) and 1.33 (95% CI: 1.01, 1,74), respectively.
The intervention had no significant effect on the
change in osteoporosis medication prescribing in high-
risk residents (OR 1.17, 95% CI: 0.91, 1.51).
The intracluster correlation coefficients for vitamin D,
calcium, and osteoporosis medication prescribing were
0.194, 0.112, and 0.052, respectively.
Sensitivity analyses
In the per protocol cohort (including only actively par-
ticipating homes), ORs were 3.06 (95% CI: 2.18, 4.29),
1.57 (95% CI: 1.12, 2.21), and 1.20 (95% CI: 0.90, 1.60)
for vitamin D, calcium and osteoporosis medications,
respectively.
Adjustment for confounding (age, sex, and high-risk
status) had little impact on effect estimates (Table 3).
Absolute prescribing change
Over the course of the trial, the mean home-level pre-
scribing change for vitamin D ≥800 IU/day was 22.2%
(95% CI: 17.6, 26.7) in the intervention arm versus 7.5%
(95% CI: 5.7, 9.3) in the control arm (between group dif-
ference = 14.7%, 95% CI: 13.1, 16.2). Mean home-level
prescribing change for calcium ≥500 mg/day was 8.8%
(95% CI: 6.6, 11.0) in the intervention arm versus 1.8%nd control long-term care homes
ol group Intervention group
,293 n = 2,185
10.7) (n = 3,274) 84.0 (11.1) (n = 2,178)
2,329/3,277) 70.4 (1,532/2,175)









Table 3 Effect of ViDOS intervention on prescribing outcomes
Outcome OR (95% CI)
Unadjusted Adjusted*
ITT cohort (n = 21 control, n = 19 intervention)
Primary: Vitamin D (≥800 IU/day) 1.82 (1.12, 2.96) 1.85 (1.13, 3.06)
Secondary: Calcium (≥500 mg/day) 1.33 (1.01, 1.74) 1.33 (1.01, 1.77)
Osteoporosis medication (high-risk residents**) 1.17 (0.91, 1.51) 1.12 (0.87, 1.44)
Per protocol cohort (n = 21 control, n = 12 intervention†)
Primary: Vitamin D (≥800 IU/day) 3.06 (2.18, 4.29) 3.14 (2.22, 4.45)
Secondary: Calcium (≥500 mg/day) 1.57 (1.12, 2.21) 1.58 (1.11, 2.24)
Osteoporosis medication (high-risk residents**) 1.20 (0.90, 1.60) 1.16 (0.87, 1.53)
*Adjusted for age, sex and high-risk status (hip fracture, spine fracture, or osteoporosis diagnosis). **Hip fracture, spine fracture, or osteoporosis diagnosis.
† Long-term care homes that were active participants in the intervention.
ITT, intention to treat; OR, odds ratio; CI, confidence interval.
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difference = 7.0%, 95% CI: 6.2, 7.9). In the per protocol
cohort, the difference in mean home-level prescribing
change between treatment arms was 27.0% (95% CI:
25.5, 28.5) for vitamin D and 13.1% (95% CI: 12.0, 14.2)
for calcium.
There was no significant difference in the home-level
prescribing change between arms for osteoporosis medi-
cations (between group difference, ITT = 3.4%, 95% CI:
2.6, 4.2; per protocol = 2.9%, 95% CI: 1.7, 4.1).
Falls and fractures
Complete falls and fracture data were received from 18
control (baseline residents, n = 2,727) and 11 interven-
tion (baseline residents, n = 1290) homes. During 9
months of data collection (three nonconsecutive pe-
riods), 18 control homes (baseline residents, n = 2,727)
reported 1,712 fallers (43.6% single fall, 19.3% two falls,
and 37.1% =3 falls) and 11 intervention homes (baseline
residents, n = 1290) reported 853 fallers (44.4% single
fall, 19.0% with two falls, and 36.6% with three falls). In
the control and intervention groups, respectively, 79/
5,128 (1.5%) and 41/2,491 (1.6%) of all reported falls re-
sulted in a fracture, including 40/79 (50.6%) and 17/41
(41.5%) hip fractures.
Discussion
Our results suggest that the ViDOS interdisciplinary,
multifaceted intervention resulted in significantly greater
uptake of appropriate vitamin D and calcium prescrib-
ing, with an absolute improvement in prescribing over
12 months of approximately 15% for vitamin D and 7%
for calcium in the ITT cohort. Although not the focus of
this report, we were also interested in the feasibility of
conducting this type of KT intervention in the LTC set-
ting. Despite challenges associated with recruitment and
retention, there was good participation by interdisciplin-
ary team members, including physicians, pharmacistsand Directors of Care, and the intervention was well re-
ceived [18].
Given that it is a tolerable, low-cost intervention that
is recommended for all older adults [29], vitamin D may
be particularly amenable to targeted change. In the com-
munity, a multifaceted intervention targeting improved
osteoporosis management demonstrated a 13% absolute
improvement in vitamin D [30]. In LTC, one KT inter-
vention involving consultation and training by specialist
osteoporosis nurses demonstrated a relative increase of
64% in calcium and vitamin D prescribing [31], but an-
other study with a similar multifaceted intervention to
ours did not demonstrate significant effects [32]. In the
latter study, participation in the intervention was low,
only high-risk residents were included in the analysis,
and the authors also suggest a possible ceiling effect due
to high baseline prescribing rates.
We did not see a significant effect for osteoporosis medi-
cation prescribing, which we hypothesize is attributable to
several factors. Management with osteoporosis medications
was reviewed in the didactic component of the educational
meetings (the standardized presentation by the expert
opinion leader), and this format has been demonstrated as
less effective [33]. In the interactive component, action
planning for change, several process and policy changes
were discussed that may have been more amenable to vita-
min D and calcium (for example, standard orders, dietary
review and changes). It has been well documented that
family physicians face a number of barriers for prescribing
osteoporosis medications in LTC [10,14], including diffi-
culty in applying general osteoporosis guidelines to LTC
residents, particularly with regard to risk assessment. Cur-
rently, general osteoporosis clinical practice guidelines [29],
are being adapted for the frail elderly residing in LTC. Fur-
thermore, providing information and recommendations at
the point of care that incorporate fracture risk may be ne-
cessary components for enhancing uptake in osteoporosis
medications and is an area for future research.
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tion was the inclusion of content and strategies that en-
couraged organizational change specific to the LTC
setting, in addition to targeting professional behavior
change. This is an important consideration, given that
several structural and environmental barriers for imple-
menting evidence-based practices within LTC homes
have been identified including a high proportion of un-
regulated staff, absence of a learning culture, high turn-
over in management, heavy regulatory and documentation
demands, routinized care rituals, and lack of familiarity
with clinical practice guidelines [34-36]. Although not all
barriers are easily modifiable, the ongoing monitoring of
organizational-level barriers (formally, three times over 12
months) was an important design feature.
Another important design component was tailoring
our intervention to interdisciplinary care teams. Com-
pared with other practice settings, physicians who prac-
tice in LTC are typically more removed from daily
patient care and more reliant on collaborative decision
making. We engaged the entire interdisciplinary care
team, including physicians, by scheduling educational
meetings in conjunction with quarterly professional ad-
visory meetings, enabling several off-site professionals to
be present simultaneously.
Although not the focus of this paper, we had good fi-
delity with our intervention including active participa-
tion in educational meetings. Other similar KT studies
in LTC, which included both physicians and LTC staff
may have had nonsignificant [15,37] or less than optimal
results [38], due to poor adherence with educational
components. In addition to scheduling educational
meetings with regularly scheduled meetings, feedback
from ViDOS participants indicated that the direct in-
volvement of an expert was highly valued [39].
This pilot study provides evidence that KT interven-
tions can be successfully applied within the LTC setting,
particularly when structured to fit the unique practice
environment and organizational structure. Previously,
these KT strategies have mainly been evaluated in non-
LTC practice settings, and studies demonstrate small to
moderate effectiveness [40]. Cochrane systematic re-
views indicate median absolute improvements in care in
the range of 4 to 12% for educational meetings (includ-
ing interactive and didactic [25]), educational outreach
[41], local opinion leaders [42], audit and feedback [43],
and computerized reminders [44]. Some organizational
interventions (for example, multidisciplinary collabor-
ation and knowledge management change) also appear
to improve some care outcomes [45], and interprofes-
sional education has shown some positive results, but is
an area requiring further study [46]. We observed simi-
lar or larger effect sizes compared with the medians re-
ported in the systematic reviews noted above.The ViDOS study had several methodological
strengths, including the recruitment of homes that were
geographically diverse and located in communities of
varied population sizes. Both the study design and ana-
lysis took into the account clustered nature of the data,
which minimizes the possibility of overestimating the
treatment effect and spuriously significant findings [47].
Nonetheless, our study is not without limitations.
While our study was generalizable in terms of geography
and community size, we had an over-representation of
chain affiliated and for-profit LTC homes compared with
provincial averages [48]. Not-for-profit LTC homes have
been associated with higher quality of care [49], al-
though multifacility chains may have greater resources
to facilitate implementation of clinical practice guide-
lines [34]. We experienced some challenges with recruit-
ment and retention, which has also been noted in other
KT trials in LTC [31,50]. This was a pragmatic RCT;
some contamination between study arms likely occurred,
which could have diluted our treatment effect. Six con-
sultant pharmacists and four Medical Directors prac-
ticed in both control and intervention homes, and
control homes may have been impacted by study activ-
ities via diffusion of messages (for example, homes in
the same corporate chain). Future trials should consider
adding region as a stratification factor to minimize con-
tamination. Both arms were subject to outside influences
including an ongoing province-wide initiative, the
Ontario Osteoporosis Strategy for LTC, [www.osteoporo-
sislongtermcare.ca) [24]].
We collected incident falls and fracture data for feasi-
bility data, and the ability to obtain standardized data
from LTC homes was a noted methodological limitation
due to different fall reporting systems. Our fracture rate
was slightly lower than the rate observed in a Canadian
study using a standardized fall risk surveillance tool [51].
However, the purpose of this pilot study was to examine
the feasibility and effectiveness of a KT model, and not
to demonstrate the effectiveness of vitamin D for redu-
cing falls and fractures. The choice of Vitamin D as our
primary outcome was based on previous studies that
demonstrated falls and fracture reduction [8,9] and our
scoping review [52], which indicated that in LTC vitamin
D supplementation was the intervention with the stron-
gest evidence for reduction of hip fractures.
Given that our intervention was multifaceted, it is dif-
ficult to determine the most influential components. In
general, multifaceted interventions may be more effect-
ive than single interventions [53], although Grimshaw et
al. [40], have shown that adding more strategies may not
improve effect sizes. We did not include measures of
organizational context (for example, work culture, and
type of leadership), which have been identified as an im-
portant factor influencing the uptake of research
Kennedy et al. Trials  (2015) 16:214 Page 9 of 11evidence [54]. Future trials should consider the interplay
with contextual factors.
Conclusions
Although RCT’s evaluating KT interventions are increas-
ing in the LTC setting [31,32,37,55], further implementa-
tion research evaluating professional and organizational
KT strategies is still greatly needed. In this study, we
demonstrated that an interdisciplinary, multifaceted
intervention could be feasibly implemented in LTC [18]
and that it improved uptake of vitamin D and calcium
prescribing. Although our topic focused specifically on
osteoporosis and fracture prevention, the ViDOS model
could potentially be applied to a wider range of topics
relevant to LTC residents.
Endnotes
aIn the framework by Locock et al. [18], an expert
opinion leader was considered distinct from peer opin-
ion leaders who are role models in daily practice and
was a ‘credible authority (often an academic or consult-
ant) able to explain the evidence and respond convin-
cingly to challenges and debate’.
bOur rationale for linking data downloads with ViDOS
session dates was to generate up-to-date audit and feed-
back reports. Six-month data were used to generate in-
terim audit and feedback reports only, not for outcome
evaluation.
cIn homes that were nonactive participants, there were
additional challenges in obtaining the data. For two non-
active intervention homes, the elapsed time between base-
line and a follow-up data download was less than 8
months. In the remaining homes, the time between base-
line and follow-up ranged from 11 to 15 months. The
variability in prescribing download dates was due to the
timing of the data downloads with educational sessions.
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